Merit Medical Systems, Inc. $MMSI Shares Bought by Diversified Trust Co.

Diversified Trust Co. grew its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 62.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,587 shares of the medical instruments supplier’s stock after buying an additional 8,679 shares during the quarter. Diversified Trust Co.’s holdings in Merit Medical Systems were worth $1,991,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Tudor Investment Corp ET AL purchased a new position in shares of Merit Medical Systems during the 3rd quarter valued at approximately $2,913,050,000. State Street Corp increased its holdings in Merit Medical Systems by 1.1% in the 2nd quarter. State Street Corp now owns 2,218,432 shares of the medical instruments supplier’s stock worth $207,379,000 after acquiring an additional 24,569 shares in the last quarter. Maverick Capital Ltd. increased its holdings in Merit Medical Systems by 8.4% in the 2nd quarter. Maverick Capital Ltd. now owns 1,379,408 shares of the medical instruments supplier’s stock worth $128,947,000 after acquiring an additional 106,897 shares in the last quarter. Wellington Management Group LLP raised its position in Merit Medical Systems by 377.7% during the third quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after acquiring an additional 980,823 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Merit Medical Systems by 6.2% during the third quarter. Dimensional Fund Advisors LP now owns 1,177,862 shares of the medical instruments supplier’s stock valued at $98,021,000 after purchasing an additional 68,711 shares in the last quarter. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Trading Up 0.8%

Shares of MMSI opened at $68.11 on Thursday. Merit Medical Systems, Inc. has a 52-week low of $66.34 and a 52-week high of $107.27. The stock has a market cap of $4.05 billion, a PE ratio of 32.13, a price-to-earnings-growth ratio of 1.95 and a beta of 0.62. The firm’s fifty day moving average is $77.34 and its two-hundred day moving average is $82.54. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. The business had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The company’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Research analysts forecast that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MMSI has been the topic of several research analyst reports. BTIG Research began coverage on shares of Merit Medical Systems in a research report on Friday, February 6th. They issued a “buy” rating and a $107.00 target price on the stock. Wells Fargo & Company downgraded shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $95.00 to $78.00 in a research report on Thursday, February 26th. Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Robert W. Baird set a $108.00 price objective on Merit Medical Systems in a report on Tuesday, December 16th. Finally, Barrington Research boosted their price objective on Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $103.33.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.